OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.
Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.